O. Moore

1.4k total citations
18 papers, 1.0k citations indexed

About

O. Moore is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, O. Moore has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in O. Moore's work include Systemic Sclerosis and Related Diseases (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Medical Imaging and Pathology Studies (4 papers). O. Moore is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Medical Imaging and Pathology Studies (4 papers). O. Moore collaborates with scholars based in United Kingdom, Australia and United States. O. Moore's co-authors include R Andrew Moore, Sheena Derry, Andrew Moore, David J. Gavaghan, Henry McQuay, Henry J McQuay, Paul M. Peloso, Huifang Wang, Arnold R. Gammaitoni and Kate Seers and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Pain and Annals of the Rheumatic Diseases.

In The Last Decade

O. Moore

17 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Moore United Kingdom 12 310 297 285 227 158 18 1.0k
Mübin Hoşnuter Türkiye 19 100 0.3× 75 0.3× 51 0.2× 472 2.1× 50 0.3× 53 930
M. Younès Tunisia 22 359 1.2× 202 0.7× 413 1.4× 514 2.3× 161 1.0× 76 1.7k
Alfons Kessels Netherlands 12 131 0.4× 35 0.1× 235 0.8× 204 0.9× 211 1.3× 24 750
Alka Kaushal India 15 89 0.3× 44 0.1× 107 0.4× 456 2.0× 139 0.9× 25 1.0k
Mohammad Bagher Owlia Iran 16 146 0.5× 80 0.3× 128 0.4× 165 0.7× 56 0.4× 48 902
Christopher B. Michelsen United States 14 254 0.8× 93 0.3× 136 0.5× 555 2.4× 271 1.7× 22 1.2k
İbrahim Keleş Türkiye 16 124 0.4× 106 0.4× 24 0.1× 176 0.8× 65 0.4× 93 900
Richard A. Harrigan United States 18 37 0.1× 129 0.4× 51 0.2× 272 1.2× 32 0.2× 48 1.0k
Yuan Jia China 18 38 0.1× 73 0.2× 37 0.1× 149 0.7× 26 0.2× 91 784
Jesse H. Marymont United States 20 54 0.2× 175 0.6× 67 0.2× 850 3.7× 78 0.5× 62 1.9k

Countries citing papers authored by O. Moore

Since Specialization
Citations

This map shows the geographic impact of O. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Moore more than expected).

Fields of papers citing papers by O. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Moore. The network helps show where O. Moore may publish in the future.

Co-authorship network of co-authors of O. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of O. Moore. A scholar is included among the top collaborators of O. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Moore. O. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
King, Jonathan D., et al.. (2023). P028 Oh No-Cardiosis! A case of systemic Nocardia nova infection. Lara D. Veeken. 62(Supplement_2).
2.
Owen, Claire, Gene‐Siew Ngian, O. Moore, et al.. (2017). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.. PubMed. 34 Suppl 100(5). 170–176. 28 indexed citations
3.
Moore, O., Susanna Proudman, Nicole Goh, et al.. (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.. PubMed. 33(4 Suppl 91). S111–6. 56 indexed citations
4.
Cross, Gail Brenda, Mandana Nikpour, O. Moore, et al.. (2014). TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study. BMC Infectious Diseases. 14(1). 93–93. 27 indexed citations
5.
McCormick, David, et al.. (2014). Does rheumatoid arthritis disease activity correlate with weather conditions?. Rheumatology International. 35(5). 887–890. 29 indexed citations
6.
Thakkar, Vivek, Wendy Stevens, O. Moore, & Mandana Nikpour. (2013). Performance of screening algorithms in systemic sclerosis‐related pulmonary arterial hypertension: a systematic review. Internal Medicine Journal. 43(7). 751–760. 12 indexed citations
7.
Stevens, Wendy, Vivek Thakkar, O. Moore, et al.. (2012). LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY. Lara D. Veeken. 51. 2 indexed citations
8.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy. 14(3). R143–R143. 91 indexed citations
9.
Nikpour, Mandana, Wendy Stevens, O. Moore, & Vivek Thakkar. (2012). Managing scleroderma: challenges in primary care. 13(6). 35–42. 1 indexed citations
10.
Ball, E., et al.. (2012). Steroid injection for inferior heel pain: a randomised controlled trial. Annals of the Rheumatic Diseases. 72(6). 996–1002. 68 indexed citations
11.
Moore, O., Nicole Goh, Tamera J. Corte, et al.. (2012). Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Lara D. Veeken. 52(1). 155–160. 135 indexed citations
12.
Morrisroe, Kathleen, Wendy Stevens, J. Byron, et al.. (2012). FRI0261 Anti-phospholipid antibodies in systemic sclerosis: Prevalence and clinical correlations. Annals of the Rheumatic Diseases. 71. 402–402. 3 indexed citations
13.
Moore, O., Nicole Goh, Tamera J. Corte, et al.. (2012). FRI0243 Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Annals of the Rheumatic Diseases. 71. 396–396. 1 indexed citations
14.
Moore, R Andrew, O. Moore, Sheena Derry, et al.. (2009). Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases. 69(2). 374–379. 194 indexed citations
15.
Moore, O., Mairead McIntyre, R Andrew Moore, Sheena Derry, & Henry J McQuay. (2009). Single dose oral tenoxicam for acute postoperative pain in adults. Cochrane Database of Systematic Reviews. 2019(5). CD007591–CD007591. 9 indexed citations
16.
Moore, R Andrew, O. Moore, Sheena Derry, & Henry J McQuay. (2008). Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Research & Therapy. 10(2). R39–R39. 34 indexed citations
17.
Moore, O., L. A. Smith, Fiona Campbell, et al.. (2001). Systematic review of the use of honey as a wound dressing. BMC Complementary and Alternative Medicine. 1(1). 2–2. 180 indexed citations
18.
Moore, Andrew, O. Moore, Henry McQuay, & David J. Gavaghan. (1997). Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain. 69(3). 311–315. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mübin Hoşnuter Breakdown of academic impact, for papers by M. Younès Breakdown of academic impact, for papers by Alfons Kessels Breakdown of academic impact, for papers by Alka Kaushal Breakdown of academic impact, for papers by Mohammad Bagher Owlia Breakdown of academic impact, for papers by Christopher B. Michelsen Breakdown of academic impact, for papers by İbrahim Keleş Breakdown of academic impact, for papers by Richard A. Harrigan Breakdown of academic impact, for papers by Yuan Jia Breakdown of academic impact, for papers by Jesse H. Marymont
Rankless by CCL
2026